Mead Johnson is finally ready for the market. A spinoff from Bristol Myers Squibb that I think is interesting and will do well.
I’ll have to try and read the prospectus quickly.
Mead Johnson will start trading on Wednesday under MJN.
Have you read up on Mead Johnson? What do you think?